scholarly journals Financial burden of cancer care under the Affordable Care Act: Analysis of MEPS-Experiences with Cancer Survivorship 2011 and 2016

2019 ◽  
Vol 13 (4) ◽  
pp. 523-536 ◽  
Author(s):  
Young-Rock Hong ◽  
Grace L. Smith ◽  
Zhigang Xie ◽  
Arch G. Mainous ◽  
Jinhai Huo
2020 ◽  
Vol 135 (2) ◽  
pp. 255-256
Author(s):  
Shawna L. Bull Phelps ◽  
Lisa A. Jackson-Moore

Author(s):  
Ryan D. Nipp ◽  
Ellen Miller Sonet ◽  
Gery P. Guy

In recent years, high health care costs and the financial burden of cancer care have received increased attention. In response to the financial burden of cancer care, patients may jeopardize their health outcomes by not properly adhering to prescribed therapies or even forgoing and delaying care in an effort to defray costs. In addition, the financial burden experienced by patients with cancer may negatively impact clinical outcomes, such as quality of life, physical and psychological symptoms, and potentially, even survival. Notably, in the current era of targeted treatment and immunotherapies for patients with cancer, the rising costs of cancer continue to remain at the forefront of patient concerns. Therefore, a critical need exists to determine how best to assist patients with the cost burden of cancer diagnosis and treatment


2014 ◽  
Vol 10 (5) ◽  
pp. e313-e320 ◽  
Author(s):  
Thomas S. Gruca ◽  
Inwoo Nam ◽  
Roger Tracy

The Affordable Care Act seeks to expand access for vulnerable populations—for example, the rural elderly—making it critical to better understand the existing system of rural cancer care delivery.


2017 ◽  
Vol 23 (3) ◽  
pp. 194-198 ◽  
Author(s):  
Xuesong Han ◽  
Ahmedin Jemal

2016 ◽  
Vol 21 (4) ◽  
pp. 467-474 ◽  
Author(s):  
Ryan D. Nipp ◽  
Hang Lee ◽  
Elizabeth Powell ◽  
Nicole E. Birrer ◽  
Emily Poles ◽  
...  

2014 ◽  
Vol 10 (5) ◽  
pp. 332-338 ◽  
Author(s):  
Kathleen M. Fenn ◽  
Suzanne B. Evans ◽  
Ruth McCorkle ◽  
Michael P. DiGiovanna ◽  
Lajos Pusztai ◽  
...  

Increased financial burden as a result of cancer care costs is the strongest independent predictor of poor quality of life among cancer survivors.


Sign in / Sign up

Export Citation Format

Share Document